Immupharma PLC Annual Report & Notice of AGM (3430H)
June 07 2017 - 02:01AM
UK Regulatory
TIDMIMM
RNS Number : 3430H
Immupharma PLC
07 June 2017
7 June 2017
ImmuPharma PLC
("ImmuPharma" or the "Company")
ANNUAL REPORT AND ACCOUNTS POSTED TO SHAREHOLDERS
NOTICE OF ANNUAL GENERAL MEETING ON 30 JUNE 2017 @ 10.30 AM
INVESTOR PRESENTATION TO FOLLOW AT 11.30 AM
VENUE: SKY LIGHT CITY, 50 BASINGHALL STREET, LONDON, EC2
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the
specialist drug discovery and development company confirms that
today the Annual Report and Accounts for the year ended 31 December
2016 has today been posted to shareholders.
This report includes the 'Annual Report of the Annual General
Meeting' ('AGM') as well as the 'Notice of the 2017 AGM', which
will be available later today, in electronic form, for download on
the Company's website www.immupharma.org.
ImmuPharma's AGM will be held on Friday 30 June at 10:30am at
Sky Light City Tower, 50 Basinghall Street, EC2V 5DE.
Investor Meeting @ 11.30am on 30 June 2017
ImmuPharma has confirmed that it will be hosting an Investor
Presentation and luncheon immediately following the Company's
Annual General Meeting at 11.30am. Please contact Lisa Baderoon at
lisa.baderoon@immupharma.com if you would like to attend this
event.
-Ends-
For further information please
contact:
ImmuPharma plc (www.immupharma.org) + 44 (0) 20 7152 4080
Tim McCarthy, Chairman
Lisa Baderoon, Head of Investor Relations
Twitter: @immupharma + 44 (0) 7721 413496
Northland Capital Partners Limited (Joint Broker)
Patrick Claridge, David Hignell, Corporate Finance
Rob Rees, Corporate Broking +44 (0)20 3861 6625
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOASSAFMMFWSELM
(END) Dow Jones Newswires
June 07, 2017 02:01 ET (06:01 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From Feb 2024 to Mar 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2023 to Mar 2024